Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: ,HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial-

Haematologica · Published 2026-07-23 · DOI 10.3324/haematol.2026.301370

Free full text

Authors (2)

Mariane De Montalembert, Haydar Frangoul

Abstract

Not available.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year

2026

Citation

Montalembert, M., Frangoul, H. (2026). Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: ,HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial-. Haematologica. https://doi.org/10.3324/haematol.2026.301370

Related articles

• Daratumumab combining with venetoclax, three-day multi-frequency decitabine, vincristine, dexamethasone (VDVD) as the salvage treatment of relapsed/refractory T-cell acute lymphoblastic leukemia · Haematologica · 2026 · Same journal
• Comparison and combination of prognostic scores for nodular lymphocytepredominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group · Haematologica · 2026 · Same journal
• Risk factors and their contributions to prognosis in multiple myeloma · Haematologica · 2026 · Same journal
• Connecting asciminib tolerability to long-term treatment persistence. Comment on: "Favorable tolerability of asciminib versus ATP-competitive tyrosine kinase inhibitors in the ASC4FIRST study of newly diagnosed patients with chronic-phase chronic myeloid leukemia" · Haematologica · 2026 · Same journal
• A pilot trial evaluating lenalidomide and oral azacitidine with radiotherapy for patients with newly diagnosed and relapsed plasmacytoma · Haematologica · 2026 · Same journal
• Enteropathy-associated T-cell lymphoma: molecular clonal evolution and its clinical consequences · Haematologica · 2026 · Same journal
• Genetic screening alters diagnosis and management in patients with immune thrombocytopenia · Haematologica · 2026 · Same journal
• Mechanisms of blood-induced joint disease in hemophilia and potential novel targets for interventions · Haematologica · 2026 · Same journal
• Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma · Haematologica · 2026 · Same journal
• Characteristics of clonal cytopenia of undetermined significance in the presence of ZRSR2 mutations · Haematologica · 2026 · Same journal